Home Cart 0 Sign in  
X

[ CAS No. 25813-24-5 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 25813-24-5
Chemical Structure| 25813-24-5
Chemical Structure| 25813-24-5
Structure of 25813-24-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 25813-24-5 ]

Related Doc. of [ 25813-24-5 ]

Alternatived Products of [ 25813-24-5 ]

Product Details of [ 25813-24-5 ]

CAS No. :25813-24-5 MDL No. :MFCD13185524
Formula : C6H5Br2NO Boiling Point : -
Linear Structure Formula :- InChI Key :VITQLRNAXLKYCU-UHFFFAOYSA-N
M.W :266.92 Pubchem ID :21766026
Synonyms :

Calculated chemistry of [ 25813-24-5 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.13
TPSA : 22.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.36 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.19
Log Po/w (XLOGP3) : 2.21
Log Po/w (WLOGP) : 2.62
Log Po/w (MLOGP) : 1.67
Log Po/w (SILICOS-IT) : 2.71
Consensus Log Po/w : 2.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.27
Solubility : 0.145 mg/ml ; 0.000543 mol/l
Class : Soluble
Log S (Ali) : -2.31
Solubility : 1.31 mg/ml ; 0.00491 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.86
Solubility : 0.037 mg/ml ; 0.000139 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.54

Safety of [ 25813-24-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 25813-24-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 25813-24-5 ]
  • Downstream synthetic route of [ 25813-24-5 ]

[ 25813-24-5 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 25813-24-5 ]
  • [ 74-88-4 ]
  • [ 2683-35-4 ]
YieldReaction ConditionsOperation in experiment
91% for 12 h; Reflux General procedure: Methyl iodide (4 mmol; 2 equiv.) was added to a solution of 1 (2 mmol) in various solvents (15 ml) and the mixture was refluxed overnight. The reaction was monitored by TLC. After completion, the solvent was removed under reduced pressure and the residue was purified by column chromatography (EtOAc: MeOH, 20:1→5:1) to obtain the products.
Reference: [1] Synthetic Communications, 2017, vol. 47, # 9, p. 872 - 877
  • 2
  • [ 25813-24-5 ]
  • [ 75-03-6 ]
  • [ 2683-35-4 ]
  • [ 90110-13-7 ]
Reference: [1] Synthetic Communications, 2017, vol. 47, # 9, p. 872 - 877
  • 3
  • [ 75-30-9 ]
  • [ 25813-24-5 ]
  • [ 2683-35-4 ]
Reference: [1] Synthetic Communications, 2017, vol. 47, # 9, p. 872 - 877
  • 4
  • [ 67-56-1 ]
  • [ 2457-48-9 ]
  • [ 25813-24-5 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.25 h;
Stage #2: at 20℃; for 19 h;
To a solution of MeOH (0.115 mL, 2.85 mmol) and THF (0.5 mL) at 0 °C was added sodium hydride (60percent dispersion, 1 14 mg, 2.85 mmol). After stirring for 15 min, Intermediate 3 IB (600 mg, 1.900 mmol) was added, and the resulting mixture was stirred at room temperature for 19 hours, diluted with water (3 mL) and extracted with EtOAc (2 x 10 mL). The combined organics were washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to yield Intermediate 31 (0.480 g, 1.798 mmol, 95percent yield) as a beige color solid. MS (ES): m/z=267.9 [M+H]+. XH NMR (400 MHz, MeOD) δ ppm 8.68 (2 H, s), 3.99 (3 H, s).
Reference: [1] Patent: WO2012/15723, 2012, A1, . Location in patent: Page/Page column 93
  • 5
  • [ 25813-25-6 ]
  • [ 124-41-4 ]
  • [ 25813-24-5 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With N-ethyl-N,N-diisopropylamine; trichlorophosphate In acetonitrile at 20℃; for 17 h; Cooling with ice; Reflux
Stage #2: at 60℃; for 0.5 h;
Compound (M-41) (10.0 g, 39.5 mmol)Was suspended in acetonitrile (50 mL)DIPEA (15 mL, 87 mmol) was added at room temperature,Phosphoryl chloride (7.4 mL, 79 mmol)Was added under cooling with ice, and the mixture was stirred under heating reflux for 17 hours. After allowing to cool, the reaction solution was added dropwise to ice water,And neutralized with sodium carbonate (11.6 g, 138 mmol).Thereafter, the mixture was extracted with ethyl acetate,The organic layer was washed with saturated brine,And dried over anhydrous sodium sulfate.The solvent was distilled off under reduced pressure,Chloro compound (yield 10.6 g, yield 99percent)As a brown solid.Chloro form (10.6 g, 39.1 mmol)Was dissolved in THF (70 mL)Sodium methoxide (28percent methanol solution,14 mL, 59 mmol) was added,Followed by stirring at 60 ° C. for 30 minutes. After cooling down,Water was added to the reaction solution, and the mixture was extracted with ethyl acetate.The organic layer was washed successively with water and saturated brine,And dried over anhydrous sodium sulfate.The solvent was distilled off under reduced pressure,Compound (VII-46) (yield 9.21 g, yield 88percent)As a yellow solid.
Reference: [1] Patent: JP2018/145180, 2018, A, . Location in patent: Paragraph 0633; 0634; 635
  • 6
  • [ 13626-17-0 ]
  • [ 124-41-4 ]
  • [ 25813-24-5 ]
YieldReaction ConditionsOperation in experiment
88% at 60℃; for 0.5 h; Compound (M-41) (10.0 g, 39.5 mmol) was suspended in acetonitrile (50 mL), DIPEA (15 mL, 87 mmol) wasadded at room temperature, phosphoryl chloride (7.4 mL, 79 mmol) was added under ice-cooling, and the mixture wasstirred with heating under reflux for 17 hr. The mixture was allowed to cool, and the reaction mixture was added dropwiseto ice water, and neutralized with sodium carbonate (11.6 g, 138 mmol). Thereafter, the mixture was extracted with ethylacetate, and the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solventwas evaporated under reduced pressure to give a chloro compound (yield 10.6 g, 99percent) as a brown solid. The chlorocompound (10.6 g, 39.1 mmol) was dissolved in THF (70 mL), sodium methoxide (28percent methanol solution, 14 mL, 59mmol) was added, and the mixture was stirred at 60°C for 30 min. The mixture was allowed to cool, water was addedto the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed successivelywith water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was evaporated under reducedpressure to give compound (VII-46) (yield 9.21 g, 88percent) as a yellow solid
79% at 20℃; for 144 h; Inert atmosphere; Schlenk technique A solution of 3,5-dibromo-4-chloropyridine (240) (249 mg, 918 μmol) and sodium methoxide (198 mg, 3.67 mmols) in 10 mL of MeOH was stirred for six days at rt Subsequently, the reaction mixture was admixed with 10 mL of water and the aqueous layer was then extracted three times with 30 ml of EtOAc. The combined organic layers were dried over anhydrous magnesium sulfate and the solvent was subsequently removed in vacuo. The purification was carried out by silica gel column chromatography (5percent EtOAc/PE). The product (192 mg, 721 μmol, 79percent) was obtained as a white solid. Rf: 0.44 (5percent EtOAc/PE). 1H NMR (500 MHz, CDCl3) δ = 8.54 (s, 2H), 3.95 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 160.84, 152.13, 116.00, 60.95. ESI-MS: m/z = 268.00 [M+H]+. HRMS (ESI): calculated for C6H6ON 79Br2: m/z = 265.88107 [M+H]+, found: m/z = 265.88105 [M+H]+. calculated for C6H6ON 79Br 81Br: m/z = 267.87902 [M+H]+, found: m/z = 267.87831 [M+H]+. calculated for C6H6ON 81Br2: m/z = 269.87697 [M+H]+, found: m/z = 269.87574 [M+H]+.
Reference: [1] Patent: EP3351533, 2018, A1, . Location in patent: Paragraph 0676; 0678
[2] Tetrahedron, 2018, vol. 74, # 35, p. 4531 - 4537
  • 7
  • [ 25813-25-6 ]
  • [ 74-88-4 ]
  • [ 25813-24-5 ]
Reference: [1] Patent: WO2014/152213, 2014, A2, . Location in patent: Page/Page column 57
[2] Patent: WO2014/152278, 2014, A2, . Location in patent: Page/Page column 56
  • 8
  • [ 626-64-2 ]
  • [ 25813-24-5 ]
Reference: [1] Patent: WO2012/15723, 2012, A1,
[2] Patent: EP3351533, 2018, A1,
[3] Patent: JP2018/145180, 2018, A,
  • 9
  • [ 25813-25-6 ]
  • [ 25813-24-5 ]
Reference: [1] Patent: WO2012/15723, 2012, A1,
[2] Tetrahedron, 2018, vol. 74, # 35, p. 4531 - 4537
[3] Patent: EP3351533, 2018, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 25813-24-5 ]

Bromides

Chemical Structure| 82257-09-8

[ 82257-09-8 ]

3-Bromo-4-methoxypyridine

Similarity: 0.85

Chemical Structure| 36953-41-0

[ 36953-41-0 ]

3-Bromo-4-pyridinol

Similarity: 0.80

Chemical Structure| 1211520-71-6

[ 1211520-71-6 ]

2,5-Dibromo-4-methoxypyridine

Similarity: 0.78

Chemical Structure| 886372-61-8

[ 886372-61-8 ]

5-Bromo-4-methoxy-2-methylpyridine

Similarity: 0.77

Chemical Structure| 1232431-11-6

[ 1232431-11-6 ]

5-Bromo-4-methoxypyridin-2-amine

Similarity: 0.75

Ethers

Chemical Structure| 82257-09-8

[ 82257-09-8 ]

3-Bromo-4-methoxypyridine

Similarity: 0.85

Chemical Structure| 1211520-71-6

[ 1211520-71-6 ]

2,5-Dibromo-4-methoxypyridine

Similarity: 0.78

Chemical Structure| 886372-61-8

[ 886372-61-8 ]

5-Bromo-4-methoxy-2-methylpyridine

Similarity: 0.77

Chemical Structure| 1232431-11-6

[ 1232431-11-6 ]

5-Bromo-4-methoxypyridin-2-amine

Similarity: 0.75

Chemical Structure| 13472-60-1

[ 13472-60-1 ]

3,5-Dibromo-2-methoxypyridine

Similarity: 0.72

Related Parent Nucleus of
[ 25813-24-5 ]

Pyridines

Chemical Structure| 82257-09-8

[ 82257-09-8 ]

3-Bromo-4-methoxypyridine

Similarity: 0.85

Chemical Structure| 36953-41-0

[ 36953-41-0 ]

3-Bromo-4-pyridinol

Similarity: 0.80

Chemical Structure| 1211520-71-6

[ 1211520-71-6 ]

2,5-Dibromo-4-methoxypyridine

Similarity: 0.78

Chemical Structure| 886372-61-8

[ 886372-61-8 ]

5-Bromo-4-methoxy-2-methylpyridine

Similarity: 0.77

Chemical Structure| 1232431-11-6

[ 1232431-11-6 ]

5-Bromo-4-methoxypyridin-2-amine

Similarity: 0.75